Page last updated: 2024-08-18

4-butyrolactone and levoleucovorin

4-butyrolactone has been researched along with levoleucovorin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adebayo, BO; Chang, TC; Deng, L; Hsiao, M; Huang, CC; Lee, WH; Lin, YC; Rao, YK; Tzeng, YM; Wang, LS; Wu, AT; Wu, CH; Yeh, CT	1

Other Studies

1 other study(ies) available for 4-butyrolactone and levoleucovorin

Article	Year
4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype. Toxicology and applied pharmacology, 2015, Oct-15, Volume: 288, Issue:2 Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Colorectal Neoplasms; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Leucovorin; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Organoplatinum Compounds; Phenotype; Signal Transduction; Spheroids, Cellular; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays	2015

Article

Year

4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.

Toxicology and applied pharmacology, 2015, Oct-15, Volume: 288, Issue:2

Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Colorectal Neoplasms; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Leucovorin; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Organoplatinum Compounds; Phenotype; Signal Transduction; Spheroids, Cellular; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2015